New support for replacing higher-potency ticagrelor (Brilinta) with clopidogrel as part of dual-antiplatelet therapy (DAPT) 30 days after stenting for acute myocardial infarction comes from
Read more
Home ยป
New support for replacing higher-potency ticagrelor (Brilinta) with clopidogrel as part of dual-antiplatelet therapy (DAPT) 30 days after stenting for acute myocardial infarction comes from
Read moreNEW YORK (Reuters Health) – In diabetic patients with critical limb ischemia (CLI), endovascular revascularization was associated with lower in-hospital mortality but more major amputations
Read more